Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea

Purpose: This regulatory post-marketing surveillance (PMS) study was performed to evaluate the safety and effectiveness of regorafenib on Korean patients with colorectal cancer (CRC), gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC) in a real-world clinical setting. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Beom, Seung-Hoon, Bae, Ki Beom, Zang, Dae Young, Bae, Joohee, Hwang, In Gyu, Kang, Hye Jin, Woo, In Sook, Shim, Byoung Yong, Bae, Byung-Noe, Cheon, Jaekyung, Oh, Sang-Bo, Ahn, Joong-Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608207/
https://www.ncbi.nlm.nih.gov/pubmed/36313033
http://dx.doi.org/10.7150/jca.74107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608207/
https://www.ncbi.nlm.nih.gov/pubmed/36313033
http://dx.doi.org/10.7150/jca.74107

Ejemplares similares